Clinical features and immune memory of breakthrough infection in children after age-appropriate 13-valent pneumococcal conjugate vaccination in Taiwan
Infection · 2025
DOI: 10.1007/s15010-024-02426-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infection, 2025. Verfasst von Chih-Ho Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Chang Gung Memorial Hospital, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Pneumococcal Vaccines, Pneumococcal Infections, Immunologic Memory, Streptococcus pneumoniae. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Chang Gung Memorial Hospital, National Science and Technology Council.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
PURPOSE: As certain vaccine serotypes are still circulating within the community during the PCV13 era, we aimed to delineate the clinical features and assess the immunity following breakthrough infections in children. METHODS: 101 PCVs-vaccinated children < 18 years with culture confirmed PCV13 serotype breakthrough infection (25/101, invasive pneumococcal disease [IPD]) was identified in Taiwan in 2015-2019. Immunoglobulin G (IgG) antibody levels, IgM+ memory B cells (MBCs), and isotype-switched immunoglobulin (sIg+) MBC specific to serotypes 3, 14, 19 A were assessed prior to and one month after an additional PCV13 booster in 9 patients. A cohort of 89 previously vaccinated, healthy children were enrolled as controls. RESULTS: The majority (88%) of the breakthrough infection occurred in children under 7 years old. Infection by serotypes 3 and 19 A increased in children aged 5-17 years in 2018-2019. The pre-booster serotype 3- and 19 A-specific IgG in both children with breakthrough infection and controls were lower than the IPD protective thresholds (2.83 µg/mL for 3; 1.00 µg/mL for 19 A). Breakthrough infected children showed higher geometric mean ratio in serotype-specific IgG, IgM+ MBCs and sIg+ MBC after an additional PCV13 booster, compared to the controls. CONCLUSIONS: Most breakthrough infections occurred in previously healthy preschool-aged children, but such infections may still occur in school-aged children due to waning immunity. Breakthrough infections may also enhance the anamnestic response elicited by PCV13.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
- Molecular Infectious Disease Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
- Department of Laboratory Medicine, Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
- Molecular Infectious Disease Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan. chchiu@adm.cgmh.org.tw.
- Graduate Institute of Clinical Medical Sciences, Chang Gung University College of Medicine, Taoyuan, Taiwan. chchiu@adm.cgmh.org.tw.
Förderung
- Chang Gung Memorial Hospital
- National Science and Technology Council
Zitieren
APA
Chen, C. H., Hsu, M. H., Ou-Yang, M. C., Yin, C. T., Li, H. C., Su, L. H., Cheng, S. S., & Chiu, C. H. (2025). Clinical features and immune memory of breakthrough infection in children after age-appropriate 13-valent pneumococcal conjugate vaccination in Taiwan. Infection. https://doi.org/10.1007/s15010-024-02426-3
Vancouver
Chen CH, Hsu MH, Ou-Yang MC, Yin CT, Li HC, Su LH, et al. Clinical features and immune memory of breakthrough infection in children after age-appropriate 13-valent pneumococcal conjugate vaccination in Taiwan. Infection. 2025. doi:10.1007/s15010-024-02426-3
BibTeX
@article{Chen2025,
author = {Chen, Chih-Ho and Hsu, Mei-Hua and Ou-Yang, Mei-Chen and Yin, Chen-Ting and Li, Hsin-Chieh and Su, Lin-Hui and Cheng, Shu-Shen and Chiu, Cheng-Hsun},
title = {Clinical features and immune memory of breakthrough infection in children after age-appropriate 13-valent pneumococcal conjugate vaccination in Taiwan},
journal = {Infection},
year = {2025},
doi = {10.1007/s15010-024-02426-3}
}
EUVIMED